Paul Batty

ESTP Congress
paul.batty@ucl.ac.uk
,

Dr Paul Batty, is an Associate Professor in Haemophilia at University College London and an Honorary Consultant in Haemostasis and Thrombosis at the Katharine Dormandy Haemophilia and Thrombosis Centre (Royal Free Hospital, London, UK).

He has a research interest in the cellular and immune consequences of gene and novel therapies for the treatment of inherited bleeding disorders. Prior to starting at UCL, he completed a three-year post-doctoral fellowship in Dr David Lillicrap’s group in Queen’s University (Canada) investigating the early and long-term fate of Adeno-associated viral gene therapy in the haemophilia dog model. The aim of these ongoing studies is to provide translational information on safety and mechanisms of action of adeno-associated viral gene therapy vectors.

In his clinical role he cares for individuals and families with bleeding and thrombotic disorders. This includes participants in haemophilia clinical gene therapy studies, as well as individuals undergoing treatment with the first licensed AAV gene therapy for severe haemophilia B (Etranacogene Dezaparvovec). He is a volunteer for the European Haemophilia Consortium (EHC), supporting a biannual update on Novel Treatments for haemophilia for patient national member organisations. He is an active member of National and International gene therapy working groups.

He has published a number of articles on gene and novel therapies in the management of bleeding disorders. He is active in promotion of research and training in haemostasis and thrombosis at undergraduate and postgraduate levels.